Similar articles

• Longitudinal study of patients with anticentromere antibody.

  Takehara K, Soma Y, Igarashi A, Kikuchi K, Tamaki T, Ishibashi Y. Takehara K, et al. Dermatologica. 1990;181(3):202-6. doi: 10.1159/000247924. Dermatologica. 1990. PMID: 2135387
• [Raynaud's phenomenon and anti-centromeric antibodies].

  Marquet R, Villar MM, Ordi J, de la Figuera M, Vilardell M. Marquet R, et al. Med Clin (Barc). 1984 Jun 16;83(3):129-30. Med Clin (Barc). 1984. PMID: 6482556 Spanish. No abstract available.
• Antibodies to centromere and centriole in scleroderma spectrum disorders.

  Sato S, Fujimoto M, Ihn H, Takehara K. Sato S, et al. Dermatology. 1994;189(1):23-6. doi: 10.1159/000246753. Dermatology. 1994. PMID: 8003781
• [Anticentromere antibodies and lung disease without skin involvement].

  Fernández-Fernández FJ, Sesma P, Facio A, Guerra JL, González-Moraleja J. Fernández-Fernández FJ, et al. An Med Interna. 1997 Apr;14(4):196-8. An Med Interna. 1997. PMID: 9181818 Review. Spanish.
• Autoantibodies and clinical subsets: relevance to scleroderma.

  Maddison PJ. Maddison PJ. Wien Klin Wochenschr. 2000 Aug 25;112(15-16):684-6. Wien Klin Wochenschr. 2000. PMID: 11020957 Review. No abstract available.